drugset / Trial / NCT00543569
A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients
RandomizedParallel-groupOpen-labelTreatment
Summary
A study to assess the safety and efficacy of Alefacept in de novo kidney transplant patients.
Timeline
- Start
- 2008-02
- Primary completion
- 2011-02
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alefacept | Protein / enzyme biologic | 15 mg | Intravenous |
| Subject | Tacrolimus | Small molecule | — | Oral |
| Comparator | Basiliximab | Monoclonal antibody | 20 mg | — |
| Background | Mycophenolate Mofetil | Small molecule | 750 mg | Oral |
| Background | Mycophenolate Mofetil | Small molecule | 1000 mg | Oral |
Indications
No indication recorded.